Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Anna Baran, MD
Advertisement
Articles by Anna Baran, MD
Advertisement
Latest Updated Articles
- Oncolytic Virus Immunotherapy: A Brief Overview and Considerations for Clinical Trial Planning
Published: December 2nd 2021 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
